Targeted rescue of synaptic plasticity improves cognitive decline in sepsis-associated encephalopathy

Mol Ther. 2024 Jul 3;32(7):2113-2129. doi: 10.1016/j.ymthe.2024.05.001. Epub 2024 May 23.

Abstract

Sepsis-associated encephalopathy (SAE) is a frequent complication of severe systemic infection resulting in delirium, premature death, and long-term cognitive impairment. We closely mimicked SAE in a murine peritoneal contamination and infection (PCI) model. We found long-lasting synaptic pathology in the hippocampus including defective long-term synaptic plasticity, reduction of mature neuronal dendritic spines, and severely affected excitatory neurotransmission. Genes related to synaptic signaling, including the gene for activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) and members of the transcription-regulatory EGR gene family, were downregulated. At the protein level, ARC expression and mitogen-activated protein kinase signaling in the brain were affected. For targeted rescue we used adeno-associated virus-mediated overexpression of ARC in the hippocampus in vivo. This recovered defective synaptic plasticity and improved memory dysfunction. Using the enriched environment paradigm as a non-invasive rescue intervention, we found improvement of defective long-term potentiation, memory, and anxiety. The beneficial effects of an enriched environment were accompanied by an increase in brain-derived neurotrophic factor (BDNF) and ARC expression in the hippocampus, suggesting that activation of the BDNF-TrkB pathway leads to restoration of the PCI-induced reduction of ARC. Collectively, our findings identify synaptic pathomechanisms underlying SAE and provide a conceptual approach to target SAE-induced synaptic dysfunction with potential therapeutic applications to patients with SAE.

Keywords: AAV-mediated overexpression; ARC; BDNF; enriched environment; hippocampus; memory dysfunction; sepsis-associated encephalopathy; synaptic plasticity.

MeSH terms

  • Animals
  • Brain-Derived Neurotrophic Factor* / genetics
  • Brain-Derived Neurotrophic Factor* / metabolism
  • Cognitive Dysfunction* / etiology
  • Cognitive Dysfunction* / genetics
  • Cognitive Dysfunction* / metabolism
  • Cognitive Dysfunction* / therapy
  • Cytoskeletal Proteins* / genetics
  • Cytoskeletal Proteins* / metabolism
  • Dependovirus / genetics
  • Disease Models, Animal*
  • Genetic Vectors / administration & dosage
  • Genetic Vectors / genetics
  • Hippocampus* / metabolism
  • Long-Term Potentiation
  • Male
  • Mice
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Neuronal Plasticity*
  • Receptor, trkB / genetics
  • Receptor, trkB / metabolism
  • Sepsis-Associated Encephalopathy* / etiology
  • Sepsis-Associated Encephalopathy* / genetics
  • Sepsis-Associated Encephalopathy* / metabolism
  • Sepsis-Associated Encephalopathy* / therapy
  • Synapses / metabolism

Substances

  • activity regulated cytoskeletal-associated protein
  • Brain-Derived Neurotrophic Factor
  • Cytoskeletal Proteins
  • Nerve Tissue Proteins
  • Receptor, trkB